The expression of ARPC5 was significantly associated with CD4+ T cell in 20 cancers, CD8+ T cell in 25 cancers, neutrophil cell in 32 cancers, macrophage cell in 27 cancers, and DC cell in 29 cancer types (Figure 6A). This evidence concerns the gene CD4 and cancer.